Samir Saba, M.D., co-director of the University of Pittsburgh Medical Center Heart and Vascular Institute, and chief ...
Cardiac Resynchronization Therapy Devices (CRT)
Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.
July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27 ...
July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...
June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...
May 14, 2021 — The U.S. Food and Drug Administration (FDA) is advising patients and caregivers to keep any consumer ...
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...
![Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.](/sites/default/files/styles/content_feed_large/public/field/image/Medtronic_ICD_recall_2021.jpg?itok=zzLWvFni)
April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac ...
April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant ...
![Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.](/sites/default/files/styles/content_feed_large/public/field/image/Opimize_EP_with_devices.jpg?itok=H9OAQAhS)
A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...
March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...
January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...
September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...
July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...
May 13, 2020 — Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) or His bundle pacing (HBP) is ...